A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax

Biochemistry and Cell Biology

Volumn 85, Issue 6, 2007, Pages 741-750

  Li, Xiaohua ^a   Hong, Liu ^a   Zhao, Yunping ^a   Jin, Haifeng ^a   Fan, Rui ^a   Du, Rui ^a   Xia, Lin ^a   Luo, Guanhong ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; CIAPIN1; Leukemia; Multidrug resistance

Indexed keywords

APOPTOSIS INHIBITORS; LEUKEMIA CELLS; MULTIDRUG RESISTANCE;

BIOASSAY; CELL DEATH; DRUG PRODUCTS; SENSITIVITY ANALYSIS; TRANSCRIPTION;

ENZYME INHIBITION;

CYTOKINE INDUCED APOPTOSIS INHIBITOR 1; DOXORUBICIN; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN P; GLYCOPROTEIN P INHIBITOR; LUCIFERASE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN INHIBITOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VERAPAMIL; VINCRISTINE;

APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; ENZYME ACTIVITY; EUKARYOTE; FLOW CYTOMETRY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HL-60 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRACELLULAR SPACE; LEUKEMIA; LUCIFERASES; P-GLYCOPROTEIN; TRANSCRIPTION, GENETIC; TRANSFECTION; UP-REGULATION; VERAPAMIL;

EUKARYOTA;

EID: 38849103854     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/O07-141     Document Type: Article

References (46)

1. Agrawal, M., Abraham, J., Balis, F.M., Edgerly, M., Stein, W.D., Bates, S., et al. 2003. Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576. Clin. Cancer Res. 9: 650-656.
2. Bader, P., Fuchs, J., Wenderoth, M., von Schweinitz, D., Niethammer, D., and Beck, J.F. 1998. Altered expression of resistance associated genes in hepatoblastoma xenografts incorporated into mice following treatment with Adriamycin or CDDP. Anticancer Res. 18: 3127-3132.
3. Banerjee, D., Mayer-Kuckuk, P., Capiaux, G., Budak-Alpdogan, T., Gorlick, R., and Bertino, J.R. 2002. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim. Biophys. Acta, 1587: 164-173.
4. Cabot, M.C., Giuliano, A.E., Han, T.Y., and Liu, Y.Y. 1999. SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells. Cancer Res. 59: 880-885.
5. Du, J., Pan, Y., Shi, Y., Guo, C., Jin, X., Sun, L., et al. 2005. Overexpression and significance of prion protein in gastric cancer and multidrug-resistant gastric carcinoma cell line SGC7901/ADR. Int. J. Cancer, 113: 213-220. doi:10.1002/ijc.20570.
6. Gaitanos, T.N., Buey, R.M., Díaz, J.F., Northcote, P.T., Teesdale-Spittle, P., Andreu, J.M., and Miller, J.H. 2004. Peloruside A does not bind to the taxoid site on b-tubulin and retains its activity in multidrug-resistant cell lines. Cancer Res. 64: 5063-5067. doi:10.1158/0008-5472.CAN-04-0771.
7. Ghalia, A.A., Rabboh, N.A., el Shalakani, A., Seada, L., and Khalifa, A. 2000. Estimation of glutathione-S-transferase and its k isoenzyme in tumor tissues and sera of patients with ovarian cancer. Anticancer Res. 20: 1229-1235.
8. Grossman, D., and Altieri, D.C. 2001. Drug resistance in melanoma: mechanisms, apoptosis, and new potential therapeutic targets. Cancer Metastasis Rev. 20: 3-11. doi:10.1023/A:1013123532723.
9. Guo, C., Ding, J., Yao, L., Sun, L., Lin, T., Song, Y., et al. 2005. Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl-2, MDR-1 and MRP-1. Int. J. Cancer, 116: 155-160. doi:10.1002/ijc.20919.
10. Hao, Z., Qiao, T., Jin, X., Li, X., Gao, J., and Fan, D. 2005. Preparation and characterization of a specific monoclonal antibody against CIAPIN1. Hybridoma, 24: 141-145. doi:10.1089/hyb.2005.24.141.
11. Hao, Z., Li, X., Qiao, T., Du, R., Hong, L., and Fan, D. 2006a. CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells. Cancer Biol. Ther. 5: 261-266.
12. Hao, Z., Li, X., Qiao, T., Zhang, J., Shao, X., and Fan, D. 2006b. Distribution of CIAPIN1 in normal fetal and adult human tissues. J. Histochem. Cytochem. 54: 417-426. doi:10.1369/jhc.5A6753.2005.
13. Hao, Z., Li, X., Qiao, T., Du, R., Zhang, G., and Fan, D. 2006c. Subcellular localization of CIAPIN1. J. Histochem. Cytochem. 54: 1437-1444. doi:10.1369/jhc.6A6960.2006.
14. Igney, F.H., and Krammer, P.H. 2002. Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer, 2: 277-288. doi:10.1038/nrc776.
15. Inoue, S., Salah-Eldin, A.E., and Omoteyama, K. 2001. Apoptosis and anticancer drug resistance. Hum. Cell, 14: 211-221.
16. Johnstone, R.W., Ruefli, A.A., and Lowe, S.W. 2002. Apoptosis: a link between cancer genetics and chemotherapy. Cell, 108: 153-164. doi:10.1016/S0092-8674(02)00625-6.
17. Labialle, S., Gayet, L., Marthinet, E., Rigal, D., and Baggetto, L.G. 2002. ranscriptional regulators of the human multidrug resistance 1 gene, recent views. Biochem. Pharmacol. 64: 943-948. doi:10.1016/S0006-2952(02)01156- 5.
18. Larsen, A.K., Escargueil, A.E., and Skladanowski, A. 2000. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol. Ther. 85: 217-229. doi:10.1016/S0163-7258(99)00073-X.
19. Lazarova, D.L., Bordonaro, M., and Sartorelli, A.C. 2001. Transcriptional regulation of the vitamin D3 receptor gene by ZEB. Cell Growth Differ. 12: 319-326.
20. Li, X., Rui, F., Hao, Z., Jin, H., Xia, L., Du, R., et al. 2008. Multidrug resistance of gastric cancer cells by downregulation of CIAPIN1 with CIAPIN1siRNA. Mol. Biol., In press.
21. Litman, T., Druley, T.E., Stein, W.D., and Bates, S.E. 2001. rom MDR to MXR: New understanding of multidrug resistance systems, their properties and clinical significance. Cell. Mol. Life Sci. 58: 931-959. doi:10.1007/PL00000912.
22. Mi, Q., Cui, B., Silva, G.L., Lim, E., Chai, H., You, M., et al. 2001. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype. Cancer Res. 61: 4030-4037.
23. Naito, M., Matsuba, Y., Sato, S., Hirata, H., and Tsuruo, T. 2002. M.S.-209, a quinoline-type reversal agent, potentiates antitumor efficacy of docetaxel in multidrug-resistant solid tumor xenograft models. Clin. Cancer Res. 8: 582-588.
24. Nakamura, T., Oka, M., Aizawa, K., Soda, H., Fukuda, M., Terashi, K., et al. 1999. Direct interaction between a quinoline derivative, M.S.-209, and multidrug resistance protein (MRP) in human gastric cancer cells. Biochem. Biophys. Res. Commun. 255: 618-624. doi:10.1006/bbrc.1999.0245.
25. Narasaki, F., Oka, M., Nakano, R., Ikeda, K., Fukuda, M., Nakamura, T., et al. 1997. Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cells. Biochem. Biophys. Res. Commun. 240: 606-611. doi:10.1006/bbrc.1997.7703.
26. Oltvai, Z.N., Milliman, C.L., and Korsmeyer, S.J. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74: 609-619.
27. Perkins, C.L., Fang, G., Kim, C.N., and Bhalla, K.N. 2000. The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis. Cancer Res. 60: 1645-1653.
28. Potocnik, U., Glavac, M.R., Golouh, R., and Glavac, D. 2001. The role of Pglycoprotein (MDR1) polymorphisms and mutations in colorectal cancer. Pflugers Arch. 442: 182-183.
29. Reed, J.C. 1999. Dysregulation of apoptosis in cancer. J. Clin. Oncol. 17: 2941-2953.
30. Ross, D.D. 2000. Novel mechanisms of drug resistance in leukemia. Leukemia, 14: 467-473. doi:10.1038/sj.leu.2401694.
31. Ruiz-Gomez, M.J., Souviron, A., Martinez-Morillo, M., and Gil, L. 2000. P-gp, glutathione and glutathione-S-transferase increase in a colon carcinoma cell line by colchicines. J. Physiol. Biochem. 56: 307-312.
32. Salinas, A.E., and Wong, M.G. 1999. Glutathione-S-transferases - a review. Curr. Med. Chem. 6: 279-309.
33. Sattler, M., Liang, H., Nettesheim, D., Meadows, R.P., Harlan, J.E., Eberstadt, M., et al. 1997. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science, 275: 983-986. doi:10.1126/science.275.5302.983.
34. Shibayama, H., Takai, E., Matsumura, I., Kouno, M., Morii, E., Kitamura, Y., et al. 2004. Identification of a cytokine-induced anti-apoptotic molecule anamorsin essential for definitive hematopoiesis. J. Exp. Med. 4: 581-592.
35. Shibuya, H., Kato, Y., Saito, M., Isobe, T., Tsuboi, R., Koga, M., et al. 2003. Induction of apoptosis and/or necrosis following exposure to antitumour agents in a melanoma cell line, probably through modulation of Bcl-2 family proteins. Melanoma Res. 13: 457-464. doi:10.1097/00008390-200310000- 00004.
36. Siddik, Z.H. 2003. Cisplatin: Mode of cytotoxic action and molecular basis of resistance. Oncogene, 22: 7265-7279. doi:10.1038/sj.onc.1206933.
37. Sinicrope, F.A., Dudeja, P.K., Bissonnette, B.M., Safa, A.R., and Brasitus, T.A. 1992. Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles. J. Biol. Chem. 15: 24995-25002.
38. Stavrovskaya, A.A. 2000. Cellular mechanism of multidrug resistance to tumor cells. Biochemistry (Mosc.), 65: 95-106.
39. Tew, K.D. 1994. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res. 54: 4313-4320.
40. Tomonaga, M., Oka, M., Narasaki, F., Fukuda, M., Nakano, R., Takatani, H., et al. 1996. The multidrug resistance-associated protein gene confers drug resistance in human gastric and colon cancers. Jpn. J. Cancer Res. 87: 1263-1270.
41. Wandel, C., Kim, R.B., Kajiji, S., Guengerich, P., Wilkinson, G.R., and Wood, A.J. 1999. P-glycoprotein and cytochrome P-450 3A inhibition: dissociation of inhibitory potencies. Cancer Res. 59: 3944-3948.
42. Waxman, D.J. 1990. Glutathione-S-transferases: role in alkylating agent resistance and possible target for modulation chemotherapy - a review. Cancer Res. 50: 6449-6454.
43. Xiao, B., Shi, Y.Q., Zhao, Y.Q., You, H., Wang, Z.Y., Liu, X.L., et al. 1998. Transduction of Fas gene or Bcl-2 antisense RNA sensitizes cultured drug resistant gastric cancer cells to chemotherapeutic drugs. World J. Gastroenterol. 4: 421-425.
44. Xiao, B., Shi, Y.Q., Zhao, Y.Q., You, H., Wang, Z.Y., Liu, X.L., et al. 2000. Suppression of P-gp induced multiple drug resistance in a drug resistant gastric cancer cell line by overexpression of Fas. World J. Gastroenterol. 6: 664-670.
45. Zhao, Y., Xiao, B., Chen, B., Qiao, T., and Fan, D. 2000. Upregualtion of drug sensitivity of multidrug-resistant SGC7901/VCR human gastric cancer cells by Bax gene transduction. Chin. Med. J. (Engl.), 113: 977-980.
46. Zhao, Y., You, H., Liu, F., An, H., Shi, Y., Yu, Q., et al. 2002. Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells. Cancer Lett. 185: 211-218. doi:10.1016/S0304-3835(02)00264-1.